News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Dr. Conrad Heilman Succeeds Dr. Joseph Tempio as CEO of Tunnell Consulting
July 15, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Tunnell Consulting, Inc. announced that its transition of the President and CEO’s role to Dr. Conrad J. Heilman, Jr., from Dr. Joseph S. Tempio was completed July 1.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Obesity
Amid Rough Waters, Regeneron Puts Nearly $2B on the Line For Chinese Obesity Drug
June 2, 2025
·
2 min read
·
Dan Samorodnitsky
Mergers & acquisitions
Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio
June 2, 2025
·
3 min read
·
Nick Paul Taylor
Layoff Tracker
Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug
June 2, 2025
·
217 min read
·
BioSpace Editorial Staff
Layoffs
Stealth Cuts 30% of Workforce Following FDA Rejection, Still Eyes Barth Approval
May 30, 2025
·
2 min read
·
Angela Gabriel